Eiji Wakamiya
Osaka Medical College
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Eiji Wakamiya.
Brain & Development | 2003
Kohji Azumagawa; Shuhei Suzuki; Takuya Tanabe; Eiji Wakamiya; Naohisa Kawamura; Hiroshi Tamai
We measured neopterin, biopterin and nitric oxide (NO) concentrations in the cerebrospinal fluid of pediatric patients with central nervous system (CNS) infectious diseases. The nitric oxide and neopterin concentrations were significantly elevated in encephalitis patients, especially in two cases with serious neurological sequelae, while the biopterin levels were not elevated. The bacterial meningitis patients, on the contrary, had high cerebrospinal fluid concentrations of neopterin and biopterin, but not of NO. Although these findings are preliminary, it may suggest that cerebrospinal fluids nitric oxide would be a useful marker to prospect neurological prognoses in the CNS infections.
Epilepsia | 2001
Takuya Tanabe; Shuhei Suzuki; Keita Hara; Shuiti Shimakawa; Eiji Wakamiya; Hiroshi Tamai
Summary: Purpose: Neuron‐specific enolase (NSE) has been established as a reliable marker of neuronal damage in various neurologic disorders. The aim of this study was to evaluate whether febrile seizures (FS) cause brain damage, based on the serum and cerebrospinal fluid (CSF) levels of NSE.
Biochemical and Biophysical Research Communications | 1987
Masakuni Tokuda; Atsunori Kashiwagi; Eiji Wakamiya; Tatsuya Oguni; Makoto Mino; Hiroyuki Kagamiyama
Glucose tolerance factor partially purified from yeast extract powder stimulated [U-14C]-D-glucose uptake to a level 5.6 times greater than the basal level in the absence of insulin in isolated adipocytes prepared from rats fed with normal laboratory chow. The factor also stimulated 3-O-methylglucose transport 2.2-fold from the basal level in the absence of insulin, but not in the presence of 8 nM insulin. Kinetic analysis revealed that glucose tolerance factor increased 3-O-methylglucose transport by decreasing the Ks value for 3-O-methylglucose with little change in the Vmax.
Brain Research | 2002
Shuichi Shimakawa; Shuhei Suzuki; Ryohei Miyamoto; Kimitaka Takitani; Katsuji Tanaka; Takuya Tanabe; Eiji Wakamiya; Fusao Nakamura; Miyuki Kuno; S. Matsuura; Yasuyoshi Watanabe; Hiroshi Tamai
Journal of Nutritional Science and Vitaminology | 1988
Hiroshi Tamai; Eiji Wakamiya; Makoto Mino; Mie Iwakoshi
No to hattatsu. Brain and development | 2001
Mototada Shichiri; Takuya Tanabe; Keita Hara; Shuhei Suzuki; Eiji Wakamiya; Hiroshi Tamai
Japanese Journal of Chemotherapy | 2003
Toyonaga Y; Keisuke Sunakawa; Takashi Motohiro; Naoishi Iwai; Yusuke Tanigawara; Hiroko Endo; Yashitake Sato; Haruo Kuroki; Masanori Minagawa; Naruhiko Ishiwada; Takeshi Tajima; Satoshi Iwata; Hideo Cho; Wataru Sunaoshi; Tatsuo Kato; Masahiro Bamba; Eiji Wakamiya; Kumiko Sugita; Takeshi Yamazaki; Naohisa Kawamura; Tsunekazu Haruta; Seikyou Furukawa; Takashige Okada; Fujimoto T; Takanobu Ishihara; Akikazu Ando; Naoli Tsumura
No to hattatsu. Brain and development | 2006
Okumura T; Eiji Wakamiya; Shuhei Suzuki; Hiroshi Tamai
Ergonomics | 2015
Hiroshi Watanabe; Tomohito Okumura; Eiji Wakamiya
No to hattatsu. Brain and development | 2005
Takuya Tanabe; Keita Hara; Mitsuru Kashiwagi; Mototada Shichiri; Shuhei Suzuki; Eiji Wakamiya; Hiroshi Tamai
Collaboration
Dive into the Eiji Wakamiya's collaboration.
National Institute of Advanced Industrial Science and Technology
View shared research outputs